
Curriculum Vitae
PERSONAL DETAILS
ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
(Role),(Level),(Duration)
- Research Training Unit Committee Member, Faculty, 01/01/2021 to present
- Examiner for OSCE 1 Paper for "Required Summative Assessment", University Malaya, 03/02/2021 to 03/02/2021
- Thesis Examiner for Master's Degree of Internal Medicine Examination , University Malaya, 17/11/2020 to 17/11/2020
- Thesis Examiner for Master's Degree of Internal Medicine Examination , University Malaya, 17/11/2020 to 17/11/2020
- Thesis Examiner for Master's Degree of Internal Medicine Examination, University Malaya, 17/11/2020 to 17/11/2020
- Examiner OSCE Paper , University Malaya, 02/09/2020 to 02/09/2020
- Assessor for Candidature Defence (Chairperson), University Malaya, 14/07/2020 to 14/07/2020
- Assessor for Thesis Seminar, University Malaya, 25/06/2020 to 25/06/2020
- Panel for Thesis Proposal Presentation, University Malaya, 23/06/2020 to 23/06/2020
- Examiner for Clinical Examination, University Malaya, 10/03/2020 to 10/03/2020
- Assessor for Candidature Defence (Chairperson), University Malaya, 25/02/2020 to 25/02/2020
- SUPERVISOR, University Malaya, 25/02/2020 to 25/02/2020
- Assessor for Thesis Seminar (Chairperson), University Malaya, 05/02/2020 to 05/02/2020
- A member of the taskforce to update the 2015 CPG for management of T2DM , National, 18/01/2020 to 11/03/2020
- Trainer for Gastroenterology Training Programme in Malaysia , National, 23/11/2017 to 23/11/2020
- Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
- Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
- Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
- Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
- Thesis Examiner for Master's Degree Examination of Internal Medicine, University Malaya, 18/11/2019 to 18/11/2019
- Thesis Examiner for Master's Degree Examination of Internal Medicine , University Malaya, 18/11/2019 to 18/11/2019
- Assessor for Master in Medical Sciences Proposal Defence , University Malaya, 16/10/2019 to 16/10/2019
- Assessor for Proposal Defence (Chairperson), University Malaya, 12/09/2019 to 12/09/2019
- Assessor for Proposal Defence, University Malaya, 12/09/2019 to 12/09/2019
- Assessor for Proposal Defence (Chairperson), University Malaya, 12/09/2019 to 12/09/2019
- Assesor for Fundamental Research Grant Scheme (FRGS) , National, 08/07/2019 to 08/07/2019
- OSCE Paper Examiner for Level 2 Professional Examinations, Session 2017/2018, University Malaya, 08/08/2018 to 08/08/2018
- Examiner for UM Clinical Examination 2017 - Masters in Internal Medicine Examination, University Malaya, 08/05/2017 to 12/05/2017
- Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
- Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
- Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
- Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
- Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
- Thesis Examiner for a master's degree of internal medicine examination, University Malaya, 21/11/2016 to 21/11/2016
- COORDINATOR, Faculty, 20/06/2016 to 29/06/2016
- Examiner for UITM Clinical Examination Part II Session May 2016 (Masters in Internal Medicine Programme), National, 17/05/2016 to 17/05/2016
- PROGRAMME COORDINATOR, International, 08/04/2016 to 10/04/2016
- 'Candidature Defence' Evaluation Seminar for Master candidate Lee Hooi leng, Faculty, 28/03/2016 to 29/03/2016
- High Degree committee members of medical department, Faculty, 14/03/2016 to 14/03/2016
- Project Coordinator for the 4th Edition of Accreditation Project under the Standard Malaysian Society for Quality in Health (MSQH) , Faculty, 07/11/2013 to 31/12/2013
- Coordinator for University of Malaya Medical Program for Phase 1 and 2, Faculty, 09/09/2013 to present
- QUALITY MANAGER, Faculty, 01/12/2010 to 31/12/2013
- Assistant Coordinator for 3rd MBBS (Additional) Clinical Examination, Faculty, 24/10/2011 to 31/10/2011
- Assistant Coordinator for 3rd MBBS Clinical Examination, Faculty, 08/08/2011 to 26/08/2011
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
(Qualification),(Field),(Institution),(Year)
- PhD, MEDICINE, UNIVERSITI MALAYA (UM)
- MRCP (UK), LAIN-LAIN, ROYAL COLLEGE OF PHYSICIANS, UNITED KINGDOM
- MBBS, PERUBATAN DAN PEMBEDAHAN, UNIVERSITI MALAYA (UM)
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
(Organisation),(Role),(Duration),(Level)
- Associate Editor, Associate Editor, 2021 to present (International)
- International Editorial Board Member, Editorial Board, 2020 to 2022 (International)
- Member, Member, 2019 to present (International)
- Scientific Co-Chair for Hepatology for Virtual Asian Pacific Digestive Week 2021, Committee Member, 2021 to 2021 (International)
- Organizing Committee Member for Virtual Asian Pacific Digestive Week 2021, Committee Member, 2021 to 2021 (International)
- Associate Editor, Associate Editor, 2018 to 2020 (International)
- Asia Pacific Digestive Week 2020, Others, 2018 to 2020 (International)
- Journal of Gastroenterology and Hepatology, Others, 2018 to 2020 (International)
- The Asia Pacific Working Party on Non-Alcoholic Fatty Liver Disease, Member, 2016 to 2020 (International)
- Gut and Obesity Asia, Member, 2014 to 2020 (International)
- Prevention, surveillance and management of non-communicable diseases in primary and secondary health-care settings for the low and middle income countries, Others, 2018 to 2019 (International)
- Journal of Clinical Imaging Science, Reviewer, 2017 to 2017 (International)
- Journal of Clinical Imaging Science, Reviewer, 2016 to 2016 (International)
SPECIALIZATION
(Area)
(Area)
Area of Expertise
PUBLICATIONS
(Title of publication in APA style)
(Title of publication in APA style)
WoS
2021
- Ting, Y. W., Kong, A. S. Y., Zain, S. M., Chan, W. K., Tan, H. L., Mohamed, Z., . . . Mohamed, R. (2021). Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort. Clinical and Molecular Hepatology, 27(3), 486-498. doi: 10.3350/cmh.2020.0162
- Ng, Y. Z., Lai, L. L., Wong, S. W., Mohamad, S. Y., Chuah, K. H., & Chan, W. K. (2021). Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease. Plos One, 16(5), 13. doi: 10.1371/journal.pone.0250300
- Tan, E. Z. Y., Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. K. (2021). Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. Journal of Gastroenterology and Hepatology, 36(3), 751-757. doi: 10.1111/jgh.15160
- Petroff, D., Blank, V., Newsome, P. N., Shalimar, Voican, C. S., Thiele, M., . . . Karlas, T. (2021). Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterology & Hepatology, 6(3), 185-198. doi: 10.1016/s2468-1253(20)30357-5
- Sang, C., Yan, H. M., Chan, W. K., Zhu, X. P., Sun, T., Chang, X. X., . . . Xie, G. X. (2021). Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Medicine, 8, 10. doi: 10.3389/fmed.2021.637652
- Andrieux-Meyer, I., Tan, S. S., Thanprasertsuk, S., Salvadori, N., Menetrey, C., Simon, F., . . . Murad, S. (2021). Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. Lancet Gastroenterology & Hepatology, 6(6), 448-458. doi: 10.1016/s2468-1253(21)00031-5
- Wong, W. K., & Chan, W. K. (2021). Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics, 43(3), 473-499. doi: 10.1016/j.clinthera.2021.01.007
- Zhou, Y. J., Gao, F., Liu, W. Y., Wong, G. L. H., Mahadeva, S., Mustapha, N. R. N., . . . Zheng, M. H. (2021). Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 54(4), 470-480. doi: 10.1111/apt.16487
2020
- Newsome, P. N., Sasso, M., Deeks, J. J., Paredes, A., Boursier, J., Chan, W. K., . . . Harrison, S. A. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterology Hepatology, 5(4), 362-373. doi: 10.1016/s2468-1253(19)30383-8
Scopus
2021
- Karuthan, S. R., Koh, P. S., Chinna, K., & Chan, W. K. (2021). Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients. The Medical journal of Malaysia, 76(2), 199-204.
- Sang, C., Yan, H., Chan, W. K., Zhu, X., Sun, T., Chang, X., . . . Xie, G. (2021). Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Frontiers in Medicine, 8. doi: 10.3389/fmed.2021.637652
Refereed Journals
2021
- M zes, F. E., Lee, J. A., Selvaraj, E. A., Jayaswal, A. N. A., Trauner, M., Boursier, J., ... & Pavlides, M. (2021). Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. (WoS)
- Ng YZ, Lai LL, Wong SW, Mohamad SY, Chuah KH, Chan WK. Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease. PLoS One. 2021 May 3;16(5):e0250300. doi: 10.1371/journal.pone.0250300. PMID: 33939744; PMCID: PMC8092664. (WoS)
- Karuthan SR, Koh PS, Chinna K, Chan WK. Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients. Med J Malaysia. 2021 Mar;76(2):199-204. PMID: 33742628. (SCOPUS)
2020
- Wong, S.W and Chan, W.K (2020). Epidemiology of non-alcoholic fatty liver disease in Asia Indian Journal of Gastroenterology. Indian Journal of Gastroenterology. (WoS)
- Newsome, P. N., Sasso, M., Deeks, J.J., Paredes, A., Boursier, J., Chan, W-K et al. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. https://doi.org/10.1016/S2468-1253(19)30383-8 (WoS)
- Eslam, M., Newsome, P. N., Anstee, Q. M., Targher, G., Gomez, M. R., Zelber-Segi, S et al. (2020). A new definition for metabolic associated fatty liver disease :an international expert consensus statement. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.03.039. (WoS)
- Gao, F., Huang, J. F., Zheng, K. I., Pan, X. Y., Ma, H. L., Liu, W. Y et al. (2020). Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.15055. (WoS)
- Chan, T. T., Chan, W. K., Wong, G. L., Chan, A. W., Nik Mustapha, N. R., Chan, S. L (2020). Positive Hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease. Am J Gastroenterol. Doi: 10.14309/ajg.00(13)588. (WoS)
- Wong, S. W., Chan, W. K., & Mohamed, R. (2020). Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. Journal of viral hepatitis, 27(12), 1297-1305. (WoS)
- Zain, S. M., Tan, H. L., Mohamed, Z., Chan, W. K., Mahadeva, S., Basu, R. C., & Mohamed, R. (2020). Use of simple scoring systems for a public health approach in the management of non alcoholic fatty liver disease patients. JGH Open, 4(6), 1155-1161. (WoS)
- Chong CCN, Lakhtakia S, Nguyen N, et al. Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial [published online ahead of print, 2020 Jun 4]. Endoscopy. 2020;10.1055/a-1172-6027. doi:10.1055/a-1172-6027 (WoS)
- Adams, L.A., and Chan, W.K. (2020). Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. Semin Liv Dis. Doi: 10.1055/s-0040-1713006. (WoS)
- Tan, E. Z-Y., Lai, L.L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., Chan, W-K . (in press). Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease in patient with diabetes mellitus. J Gastroen Hepatol. (WoS)
- Yu, M. L., El Kassas Sr, M., Lam, B. P., Esmat, G., Femandez, M. C., Ferret, M. A. B., ... & Gordon, S. C. (2020). Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry . [Abstract]. Hepatology, 72, 598A-599A. (WoS)
- Pitisuttithum, P., Chan, W. K., Piyachaturawat, P., Imajo, K., Nakajima, A., Seki, Y et al. (2020). Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. BMC Gastroenterology, 20, 1-9. Doi: 10.1186/s12876-020-01240-z. (WoS)
- Yilmaz, Y., Yu, M. L., Lam, B. P., Ferret, M. A. B., Papatheodoridis, G., Chan Sr, W. K., ... & Isakov, V. A. (2020). The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry . [Abstract]. Hepatology, 72, 471A-471A. (WoS)
- Younossi, Z., Yilmaz, Y., El Kassas, M., Wong, V. W. S., Duseja, A. K., M ndez-Sanchez, N., ... & Alswat, K. (2020). Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians. [Abstract]. Hepatology, 73, S440. (WoS)
- Zhang, X., Goh, G. B. B., Chan, W. K., Wong, G. L. H., Fan, J. G., Seto, W. K., ... & Kim, S. U. (2020). Unhealthy lifestyle habits and physical inactivity among Asian patients with non alcoholic fatty liver disease. Liver International, 40(11), 2719-2731. (WoS)
- Wong, G. L-H., Vincent Wong, W-S., Thompson, A., Jia, J., Hou, J., Lesmana, C.R.A., et al. (2020). Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. Doi.org/10.1016/S2468-1253(20)30190-4. (WoS)
- Younossi, Z. M., Yilmaz, Y., Yu, M. L., Wong, V. W. S., Castellanos Fernandez, M., Isakov, V. A., ... & Bugianesi, E. (2020). Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH Registry [Abstract]. Hepatology, 72, 426A-427A. (WoS)
- Chuah, K. H., Lai, L. L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., and Chan, W. K. ( 2020) Liver stiffness measurement in non alcoholic fatty liver disease: two is better than one. Journal of Gastroenterology and Hepatology, https://doi.org/10.1111/jgh.14978. (WoS)
- Eslam, M., Sarin, S. K., Wong, V. W. S., Fan, J. G., Kawaguchi, T., Ahn, S. H., ... & Alam, S. (2020). The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International, 1-31. (WoS)
- Tan, H. L., Zain, S. M., Eng, H. S., Mohamed, Z., Mahadeva, S., Chan, W. K., ... & Mohamed, R. (2020). Allele HLA DQB1* 06 reduces fibrosis score in patients with non alcoholic fatty liver disease. Hepatology Research, 50(8), 947-954. (WoS)
2019
- Wong VW, Irles M, Wong GL, Shili S, Chan AW, Merrouche W, Shu SS, Foucher J, Le Bail B, Chan WK, Chan HL, de Ledinghen V. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019, in press. (WoS)
- Chuah, K., Chan, W. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Curr Hepatology Rep 18, 492 502 (2019) doi:10.1007/s11901-019-00493-x (Non-WoS/Non-SCOPUS)
- Chan WK, Treeprasertsuk S, Goh GB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VW. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis. Clin Gastroenterol Hepatol 2019, in press. (WoS)
- Chuah KH, Wan Yusoff WNI, Sthaneshwar P, Nik Mustapha NR, Mahadeva S, Chan WK. MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis. Liver Int 2019, in press. (WoS)
- Kamarajah SK, Khoo S, Chan WK, Sthaneshwar P, Nik Mustapha NR, Mahadeva S. Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis. JGH Open 2019, in press. (Non-WoS/Non-SCOPUS)
- Chuah KH, Chan WK. Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis. Liver Int 2019, in press. (WoS)
- Leong WL, Lai LL, Nik Mustapha NR, Vijayananthan A, Rahmat K, Mahadeva S, Chan WK. Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2019, in press (WoS)
- Khoo S, Wong VW, Goh GB, Fan JG, Chan WK, Seto WK, Chow WC. Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2019, in press. (WoS)
- Chan WK, Wong VW. A new bile acid treatment for non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol 2019, in press. (WoS)
- Jayaraman, T., Lee, Y.Y., Chan, W.K., and Mahadeva, S. Epidemiological differences of common liver conditions between Asia and the West. Journal of Gastroenterology and Hepatology. (2019), doi: 10.1002/jgh3.12275. (WoS)
- Harry, S., Lee, L. L., Nik Mustapha, N.R., Abdul Aziz, Y.F., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W.K. (in press). Volumetric liver fat fraction determines grade of steatosis more accurately than controlled attenuation parameter in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology (2019). doi: https://doi.org/10.1016/j.cgh.2019.08.023. (WoS)
- Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK. Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. Dig Dis Sci 2019, in press. (WoS)
- Fu, C., Wai, J.W., Nik Mustapha, N.R., Irles, M., Lai-Hung Wong, G., Mahadeva, S., Shili, S., Wing-Hung Chan, A., Merrouche, W., Lik-Yuen Chan, H., Foucher, J., Le Bail, B., Wai-Sun Wong, V., Chan, W.K., de L dinghen, V. Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology (2019), doi: https://doi.org/10.1016/j.cgh.2019.09.027. (WoS)
2018
- Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW. Clinical features and treatment of non-alcoholic fatty liver disease across the Asia Pacific region the GO ASIA initiative. Aliment Pharmacol Ther 2018, in press. (WoS)
- Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JP, Sarin SK, Badea R, Lee HW, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Impact of Controlled Attenuation Parameter on Detecting Fibrosis using Liver Stiffness Measurement. Aliment Pharmacol Ther 2018, in press. (WoS)
- Chan WK, Dan YY, Wong VWS, for the GO ASIA Initiative. (2018). Editorial: NAFLD in Asia clinical associations with advanced disease become clearer Authors reply. Aliment Pharmacol Ther, in press. (WoS)
- Lai, L.L., Wan Yusoff, W.N.I., Vethakkan, S.R., Nik Mustapha, N.R., Chan W.K., (2018).Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. Journal of Gastroenterology and Hepatology. doi:10.1111/jgh.14577 (WoS)
- Kamarajah, S.K., Chan, WK., Nik Mustapha, N.R. et al., (2018) Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. Hepatol Int. (WoS)
- Tan, E. C., Tai, M. S., Chan, W., & Mahadeva, S. (2018). Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community. JGH Open, 1-9. doi:10.1002/jgh3.12114 (Non-WoS/Non-SCOPUS)
- Chan WK, Yeoh KY, Lim CY, Lai SM, Lee JY, Leow AHR, Goh KL.(in press) Hepatitis B virus infection among children of hepatitis B surface antigen positive mothers in a Malaysian hospital. Med J Malaysia. (Non-WoS/Non-SCOPUS)
- Khoo, S., Chan, W.K., & Mahadeva, S. (2018). Endoscopic management of colonoscopy-related perforation. Journal of Digestive Endoscopy, 9(20),47-52. (Non-WoS/Non-SCOPUS)
- Wong SW, Ting YW, Chan WK. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. JGH Open 2018, 1-7. (Non-WoS/Non-SCOPUS)
- Chan WK, Nik Mustapha NR, Mahadeva S, Wong VW, Cheng JY, Wong GL. Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis? J Gastroenterol Hepatol 2018;33:1787-1795 (WoS)
2017
- Lee-Lee Lai, Wah-Kheong Chan, Pavai Sithaneshwar, Nik Raihan Nik Mustapha, Khean-Lee Goh & Sanjiv Mahadeva (2017) Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. PLoS ONE 12(4): e0174982. (WoS)
- Say-Yee Loo, Wah-Kheong Chan. Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 2017. doi: 10.21037/hbsn.2017.03.06 (Non-WoS/Non-SCOPUS)
- Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wai-Sun Wong V, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Sik Jung K, Marcellin P, Filice C, Mahadeva S, Lai-Hung Wong G, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis. J Hepatol 2017, 66(5): 1022-1030. (WoS)
- Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol 2017, in press (WoS)
- Chan WK, Nik Mustapha NR, Wong GL, Wong VW, Mahadeva S. Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population, UEG Journal 2017; 5(1): 76-85. (WoS)
- Wah Kheong C, Nik Mustapha NR, Mahadeva S. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017;15(12):1940-9 e8. (WoS)
- Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups. J Gastroenterol Hepatol 2017, in press. (WoS)
- Huiyan L, Chan WK, Neto MG. Endoscopic sleeve gastroplasty: case report, technique and literature review. J Dig Dis 2017, in press. (WoS)
2016
- Ahmad Najib Azmi, Wah-Kheong Chan, Sanjiv Mahadeva, Khean-Lee Goh. Split-dose low volume bowel preparation, a feasible option for preparation for colonoscopy. Endoscopy 2016; 48(2): 197. (WoS)
- Chan WK, Wong VW. Oxidized low-density lipoprotein in non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2016; 31(9): 1516-18. (WoS)
- Jianyi Calvin Koh, Wai Mun Loo, Khean-Lee Goh, Kentaro Sugano, Wah-Kheong Chan, Wai-Yan Philip Chiu, Myung-Gyu Choi, Sutep Gonlachanvit, Wei-Jei Lee, Wei-Jie Jonathan Lee, Yeong Yeh Lee, Laurentius A Lesmana, You-Ming Li, Chun-Jen Liu, Bunzo Matsuura, Atsushi Nakajima, Enders Kwok Wai Ng, Jose D Sollano, Simon Kin-Hung Wong, Vincent Wai-Sun Wong, Yunsheng Yang, Khek-Yu Ho, Yock-Young Dan. Asian Consensus on the Relationship between Obesity and Gastrointestinal and Liver Diseases. J Gastroenterol Hepatol 2016; 31(8): 1405-13. (WoS)
- Chee-Chiat Liong, Sarala Ravindran, Gnana Kumar Gnanasuntharam, Edmund Fui-Min Chin, Peng-Soon Koh, Wah-Kheong Chan. Enteropathy-associated T-cell lymphoma: an extremely rare cause of chronic diarrhoea. Med J Malaysia 2016; 71(2): 88-90. (SCOPUS)
2015
- Zain SM, Mohamed Z, Pirmohamed M, Tan HL, Alshawsh MA, Mahadeva S, Chan WK, Mustapha NR, Mohamed R. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non- alcoholic fatty liver disease. Sci Rep. 2015; 5: 13306. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int. 2015; 9(4): 594-602. (WoS)
- Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver dis-ease in centrally obese but not in non-centrally obese patients with diabetes mellitus. Asia Pac J Clin Nutr. 2015; 24(2): 289-98. (WoS)
- Ahmad Najib Azmi, Wah-Kheong Chan, Khean-Lee Goh. Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy. J Dig Dis. 2015; 16(9): 537-40. (WoS)
- Rajvinder Singh, Mahesh Jayanna, Jennie Wong, Lee Guan Lim, Jun Zhang, Jing Lv, Dong Liu, Yi-Chia Lee, Ming-Lun Han, Ping-Huei Tseng, Vikneswaran Namasivayam, Rupa Banerjee, Noriya Uedo,Wah Kheong Chan, Shiaw Hooi Ho, Shi-yao Chen, Shobna Bhatia, Kohei Funasaka, Takafumi Ando, Justin Wu, Cosmas Lesmana, William Tam, Wen-Lun Wang, Chi-Yang Chang, Hwoon-Yong Jung, Kee Wook Jung, Muhammad Begawan Bestari, Kenshi Yao, Vui Heng Chong, Prateek Sharma, Khek-Yu Ho. Narrow-band imaging and white- light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett s esophagus: results of the Asia-Pacific Barrett s Consortium. Endoscopy International Open. 2015; 3(1): E14-8. (Non-WoS/Non-SCOPUS)
2014
- Zain SM, Rosmawati M, Cooper D, Razali R, Rampal S, Mahadeva S, Chan WK, Anwar A, Nurul SMR, Anis SF, Cheah PL, Basu RC, Tan HL, Mohamed Z. Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non- alcoholic fatty liver disease. PLOS ONE 2014;9 (4):e95604 , PLOS ONE 9(4):E95604 APRIL 2014. Impact Factor: 3.53. DOI: 10.1371/journal.pone.0095604 (WoS)
- Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography- diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clin Res Hepatol Gastroenterol. 2014; 38(3): 284-91. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. PLoS One. 2014; 9(9): e105903. (WoS)
- Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sithaneshwar, Khean-Lee Goh. Non-alcoholic fatty liver disease in a young multiracial Asian population - a worrying ethnic predilection in Malay and Indian males. Hepatol Int. 2013; 8(1); 121-7. (WoS)
- Chan W. K., Najib Azmi, Mahadeva S., Goh K. L. (2014). Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy. World J Gastroenterol. 2014; 20(39): 14488-94. (WoS)
- Wah-Kheong Chan, Ida Normiha Hilmi, Phaik-Leng Cheah, Khean-Lee Goh. Progression of non-alcoholic fatty liver disease - a prospective clinicopathological follow-up study. J Dig Dis. 2014; 15(10): 545-52. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29(7): 1470-6. (WoS)
2013
- Wah-Kheong Chan, Alexander Tong-Boon Tan, Vethakkan Shireene Ratna, Pei-Chien Tah, Vijayananthan Anushya, Khean-Lee Goh. Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetics Prevalence and Predictive Factors in a Multi-Racial Hospital Clinic Population in Malaysia. J Gastroenterol Hepatol 2013, 28 (8): 1375 - 83. (WoS)
- Chan WK, Roslani AC, Law CW, Goh KL, Mahadeva S. 2013. Clinical outcomes and direct costing of endoluminal clipping compared to surgery in the management of iatrogenic colonic perforation. J Dig Dis. 2013; 14(12):670-5. doi: 10.1111/1751-2980.12097 (WoS)
- Wah-Kheong Chan, Khean-Lee Goh. Epidemiology of a Fast-Emerging Disease in the Asia Pacific Region - Non-Alcoholic Fatty Liver Disease (NAFLD). Hepatol Int. 2013; 7(1): 65-71. (WoS)
2012
- Wah-Kheong Chan, Jaganathan Vijayasangkar, Sanjiv Mahadeva. Cyclosporine Rescue Therapy in Autoimmune Liver Cirrhosis: A Case Report. Turkish Journal of Gastroenterology 2012. (WoS)
- Wah-Kheong Chan, Khean-Lee Goh. Evaluation of Patient Satisfaction of an Outpatient Colonoscopy Service in an Asian Tertiary Care Hospital. Gastroenterology Research and Practice 2012. (WoS)
- Khean-Lee Goh, Wah-Kheong Chan. Commentary: changing aetiology of peptic ulcers. Alimentary Pharmacology and Therapeutics 2012. (WoS)
- Najib Azmi, Wah-Kheong Chan, Khean-Lee Goh. Evaluation of patient satisfaction of an outpatient gastroscopy service in an Asian tertiary care hospital. BMC Gastroenterology 2012, 12:96. (WoS)
2011
- Sanjiv Mahadeva, Wah-Kheong Chan, Mohammed Mohazmi, Ramanujam Sujarita, Khean-Lee Goh. A validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population. J Gastroenterol Hepatol. 2011 Jun 8. doi: 10.1111/j.1440-1746.2011.06806.x. [Epub ahead of print] (WoS)
- Wah-Kheong Chan, Arjunan Saravanan, Jeeta Manikam, Khean-Lee Goh, Sanjiv Mahadeva. Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy. BMC Gastroenterol 2011. Jul 28;11:86. (WoS)
- Khean-Lee Goh, Wah-Kheong Chan, Seiji Shiota, Yoshio Yamaoka. 2011. Epidemiology of Helicobacter pylori Infection and Public Health Implications. Helicobacter 16: 1 9. (WoS)
Article in Proceedings
2021
- Younossi, Z., Yilmaz, Y., El-Kassas, M., Duseja, A. K., Hamid, S. S., Esmat, G., ... & Stepanova, M. (2021, July). The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry. In Journal of Hepatology (Vol. 75, pp. S655-S655). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
- Younossi, Z., Harrison, S., Newsome, P. N., Chan, W. K., Yilmaz, Y., de Ledinghen, V., ... & Sanyal, A. (2021, July). Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S257-S257). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
- Zhou, Y. J., Gao, F., Liu, W. Y., Wong, G. L. H., Mahadeva, S., Raihan Nik Mustapha, N., ... & Zheng, M. H. (2021). Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics.
- Mozes, F., Lee, J., Selvaraj, E., Jayaswal, A., Trauner, M., Boursier, J., ... & Pavlides, M. (2021, July). Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S259-S260). RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS: ELSEVIER.
- LS Zee, CK Huat, B Ruveena, K Stanley, S Shahreedhan, CW Kheong, HS Hooi, M Rosmawati, H Ida, GK Lee, M Sanjiv. The spectrum of gastrointestinal and liver diseases has an ethnic predilection: observations from a specialist clinic in Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 40
- Wong WK, Lim SK, Ganapathy S, Chan WK. Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 49.
- Tan SS, Mohd Said HRH, Abu Hassan MR, Omar H, Tee HP, Chan WK, Kumar S, Mustafa M, Md Salleh MF, Adnan SD, Thongsawat S, Thetket K, Avihingsanon A, Khemnark S, Salvadori N, Brachet L. Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia. Journal of Gastroenterology and Hepatology. 36 (Suppl. 2): 259.
2020
- Tan S.S., Mohd. Said R., Abu Hassan M.R., Omar H., Tee H.P., Chan W.K., et al. (2020, December 4-5). Concordance between FibroScan and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia [Poster presentation]. International Viral Hepatitis Elimination Meeting (IVHEM) 2020. https://dndi.org/events/2020/international-viral-hepatitis-elimination-meeting-ivhem-2020/.
2019
- Khoo S, Wong VW, Goh GB, Fan JG, Chan WK, Seto WK, Chow WC. Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients. Hepatol Int 2019; 13(Suppl 1): S196. (WoS)
- Tan H.L., Shahrani S., Mohd. Zain S., Mohamed Z., Chan W.K., Mahadeva S., & Mohamed R. (2019). Non-Invasive Scoring Systems for the Diagnosis of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) in a Malaysian Cahort. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
- Chuah K.H., Lai L.L., Vethakkan S.R.,Nik Mustapha N.R., Mahadeva S., & Chan W.K. (2019). Liver stiffness measurement in non-alcoholic fatty liver disease: two is better than one. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
- Chuah K.H., Wan Yusoff W.N.I., Sthaneshwar P., Nik Mustaffa N.R., Mahadeva S., & Chan W.K. (2019). MACK-3 (Combination of HOMA, AST, CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
- Khoo S., Sun Wong V.W., Bee Goh G.B., Fan J., Chan W.K., Seto W.K., & Chow W.C. (2019). Prescription of Statin and Low-Density Lipoprotein Cholestrol Treatment Targets in Non-Alcoholic Fatty Liver Disease Petients. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
- Lee C.C., Alex H.R., & Chan W.K. (2019). Fibroscan as a Non-Invasive Approach to Predict the Presence and Size of Varices in the Malaysian Cirrhotic Population. Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019. (Non-WoS/Non-SCOPUS)
2018
- Andrieux-Meyer,I.,Tan, S-S., Salvadori,N., Simon, F., Cressey, T.R., Said,H.R.H.M.A.,... & Murad, S. (2018).Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial. Journal of Hepatology, 68 (1),S123. https://doi.org/10.1016/S0168-8278(18)30428-8 (WoS)
- Lai, L.L., Vethakkan, S., Mustapha, N.R.N., Mahadeva, S., Chan, W.K. (2018). A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus. Journal of Hepatology, 68 (1), S110. https://doi.org/10.1016/S0168-8278(18)30428-8 (WoS)
- House, M., Lai, L.L., Chan, W.K.,Mustapha, N.R.N., Vijayananthan,A., Mahadeva, S., & Pierre, T.S. (2018). A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology, 68 (1), S565. https://doi.org/10.1016/S0168-8278(18)31387-4 (WoS)
- Menon, S.H., Lai, L.L., Chan, W.K.,Mustapha, N.R.N., Vijayananthan,A., & Mahadeva, S. (2018). Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard. Journal of Hepatology, 68 (1), S569 S570. https://doi.org/10.1016/S0168-8278(18)31396-5. (WoS)
- Charing Chong, Sundeep Lakhtakia, Kazuo Hara et al.(2018) Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study. Proceeding of Gastrointestinal Endoscopy, 87(6), AB319. doi.org/10.1016/j.gie.2018.04.1688 (Non-WoS/Non-SCOPUS)
- Harry, S., Vijayananthan, A., Chan, W.K., Rahmat, K., Faridah, Y. (2018) A Comparison of the Hepafat-Scan and Fibroscan Controlled Attenuation Parameter in the Estimation of Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease Using Histology as the Reference Standard, Annual Scientific Meeting of MSGH (GUT2018), 85. (Non-WoS/Non-SCOPUS)
- Chan, W.K (2018) Current Therapies - What Has Promise? What Does Not?. Annual Scientific Meeting of MSGH (GUT2018), 41 (Non-WoS/Non-SCOPUS)
- Chung, Y.C., Tan, S.S., Chan, W.K., Chin, K.T., Hoe, C.H., Lee, Y.Y. (2018) Direct Acting Anti-Viral (DAA) in Hepatitis C Virus (HCV) Patients: Early Real-World Data From Malaysia. Annual Scientific Meeting of MSGH (GUT2018). 71 (Non-WoS/Non-SCOPUS)
- Lai, L.L., Vethakkan, S. R., Nik Mustapha, N.R., Mahadeva, S., Chan, W.K. (2018) Empagliflozin for the treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus. Annual Scientific Meeting of MSGH (GUT2018), 58 (Non-WoS/Non-SCOPUS)
- Lai, L.L., Wan Yusoff, W.N.I., Vethakkan, S.R., Nik Mustapha, N.R., Chan W.K., (2018) Screening for Non-alcoholic Fatty Liver Disease and Advance Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Annual Scientific Meeting of MSGH (GUT2018). 59 (Non-WoS/Non-SCOPUS)
- Leong, W.L., Lai, L.L., Nik Mustapha, N.R., Vijayananthan, A., Rahmat, K., Mahadeva, S., Chan, W.K. (2018) Comparing Shear Wave Elastography and Transient Elastography for the Diagnosis of Fibrosis Stages in Patients with Non-alcoholic Fatty Liver Disease Using Liver Biopsy as the Reference Standard. Annual Scientific Meeting of MSGH GUT 2018, 43. (Non-WoS/Non-SCOPUS)
2017
- Sivesh K Kamarajah, Wah Kheong Chan, Nik Raihan Mustapha, Sanjiv Mahadeva, Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 36 (Non-WoS/Non-SCOPUS)
- Pitisuttithum, P., Chan, W. K., Imajo, K., Nakajima, A., Seki, Y., Kasama, K., Kakizaki, S., Fan, J. G., Song, M. J., Yoon, S. K., Dan, Y. Y., Lesmana, L. A., Ho, K. Y., Goh, K. L., Wong , V., Treeprasertsuk, S. (2017).The high prevalence and predictors of advance fibrosis in elderly patients with liver biopsy confirmed non-alcoholic fatty liver disease (NAFLD)-The GOASIA STUDY, American association for the study of liver disease 2017, pg S-1199. (Non-WoS/Non-SCOPUS)
- Wah Kheong Chan , Sombat Treeprasertsuk , Kento Imajo , Atsushi Nakajima , Yosuke Seki , Kazunori Kasama , Satoru Kakizaki , Jian Gao Fan , Myeong Jun Song , Seung Kew Yoon , Yock Young Dan , Laurentius Lesmana , Khek Yu Ho , Khean Lee Goh , Vincent Wai Sun Wong (2017) Non-alcoholic fatty liver disease- demographic features, risk factors and treatment practices across the Asia Pacific region-the GOASIA initiative, American association for the study of liver disease 2017. (Non-WoS/Non-SCOPUS)
- Lai LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, Goh KL, Mahadeva S. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in nonalcoholic fatty liver disease. J Hepatol; 66(1): S676. . (WoS)
- Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki K, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VWS. Non-alcoholic fatty liver disease demographic features, risk factors and treatment practices across the Asia Pacific region the GO ASIA initiative. J Hepatol 2017; 66(1): S595. (WoS)
- Sumitra Ropini Karuthani, Wah Kheong Chan, Peng Soon Koh, Karuthan Chinna, Comparing the BCLC and HKLC staging systems in the management of hepatocellular carcinoma in a tertiary center in Malaysia, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 154-194. (WoS)
- Yeong Yeh Lee, Jianyi Calvin Koh, Mung Seong Wong, Rona Marie Lawenko, Sombat Treeprasertsuk, Siok Chiang Fan, Wai Mun Loo, Wah Keong Chan, Vincent WS Wong, Ajay Duseja, Sutep Gonlachanvit, Murdani Abdullah, Yeon-Young Chuah, Jose Sollano, Myung-Gyu Choi, Kentaro Sugano, Khean Lee Goh, Khek Yu Ho, Dan Yock Young, GO ASIA WORKING GROUP, Perception and bariatric practices of obesity-related gastrointestinal (GI) disease among Asian GI practitioners: GOASIA working group initiative, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 26-28. (WoS)
- Wah Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong, Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?, J Gastroenterol Hepatol 2017; 32 (Suppl. 3): 154-194. (WoS)
- Wah Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong, Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 43 (Non-WoS/Non-SCOPUS)
- Stanley Khoo, Wah Kheong Chan, KL Goh, A Substantial Proportion of Patients with Chronic Hepatitis B have Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study Using FibroScan at Major Tertiary Hospital in Malaysia, Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2017, Page 41 (Non-WoS/Non-SCOPUS)
- Wah Kheong Chan, Management of NAFLD case discussion. Paper presented at the MEMS Annual Congress 2017 (MAC 8), (Non-WoS/Non-SCOPUS)
2016
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A randomized, double-blind, placebo- controlled trial of silymarin for the treatment of non-alcoholic steatohepatitis. Hepatol Int 2016; 10 (Suppl 1.): S455. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis. J Hepatol 2016; 64 : S225-226. (WoS)
- Wah-Kheong Chan, Kee-Ying Yeoh, Chia-Ying Lim, Su-Meng Lai, Jac-Lyn Lee, Alex Hwong-Ruey Leow, Khean- Lee Goh. A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 56 (Non-WoS/Non-SCOPUS)
- Stanley Khoo, Wah Kheong Chan, Sanjiv Mahadeva, Nik Raihan Nik Mustapha. Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients.Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 68 (Non-WoS/Non-SCOPUS)
- Ruveena Rajaram & Wah-Kheong Chan. Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 76 (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 80 (Non-WoS/Non-SCOPUS)
- Wah Kheong Chan. (2016, Nov). An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative.Paper presented at the Asian Pacific Digestive Week APDW 2016, Kobe, Japan.
- Wah Kheong Chan. (2016, Nov). New Therapeutic Options for NAFLD.Paper presented at the Asian Pacific Digestive Week APDW 2016, Kobe, Japan.
- Chan, W.K., Yeoh, K.Y.,LIM, C.Y., LAIL, S.M., Lee, J.L., Leow, A.H.R.,...& Goh, K.H. (2016). Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 356. 10.1111/jgh.13540 (WoS)
- Li, E.T.C., Tai, S.M.L., Chan, W.K., Abd Rahman, R. & Mahadeva, S. (2016). A Study of Non-Alcoholic Fatty Liver Disease Using Transient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-aged Malaysian Population. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 385. 10.1111/jgh.13540 (WoS)
- Khoo,S.,Chan, W.K., Mahadeva, S. & Nik Mustapha, N.R.(2016). Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Ballooning and Adult NAFLD Patients: Non-invansive Biomarkers in Diagnosis of Non-Alcoholic Steatohapetitis (NASH) in Adult Patients. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 389. 10.1111/jgh.13540 (WoS)
- Chan, W.K., Nik Mustapha, N.R., & Mahadeva, S. (2016). Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study. Proceedings of the Asian Pacific Digestive Week APDW 2016 31, 356. 10.1111/jgh.13540 (WoS)
- E.C.L. Tan, S.M.L. Tai, Wah-kheong Chan, Sanjiv Mahadeva. A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort. Annual Scientific Congress of the Malaysian Society of Gastroenterolgy and Hepatology GUT 2016, Page 62 (Non-WoS/Non-SCOPUS)
2015
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 2015; 30 (Suppl. 4): 324. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha. Sanjiv Mahadeva. Silymarin for the treatment of non- alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, page 34 (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, page (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? J Gastroentrol Hepatol 2015; 30 (Suppl. 4): 327. (WoS/SCOPUS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. J Hepatol 2015; 62(2): S269. (WoS)
- Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Hepatol Int 2015; 9 (Suppl 1): S362. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A novel 2 step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int 2015; 9 (Suppl 1): S372-3. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind placebo-controlled trial. EMJ Hepatol 2015; 3(2): 84-6. (Non-WoS/Non-SCOPUS)
2014
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 48 (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 49. (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2014, page 50. (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. J Gastroenterol Hepatol. 2014; 29 (Suppl. 3): 182-3. (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2014; 29 (Suppl. 3): 183-4 (WoS)
- Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. Hepatol Int. 2014; 8(Suppl. 1): 353-4. (WoS)
2013
- Wah-Kheong Chan, Najib Azmi, Sanjiv Mahadeva, Khean-Lee Goh. Reduced-volume PEG-ELS plus bisacodyl split- dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 72. (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei-Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long- standing poorly controlled diabetics. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 55. (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sithaneshwar, Khean-Lee Goh. Non-alcoholic fatty liver disease in young adults worrying ethnic differences in a multi-racial Asian population in Malaysia. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 56. (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Alexander Tong-Boon Tan, Vethakkan Shireene Ratna, Pei-Chien Tah, Vijayananthan Anushya, Khean-Lee Goh. Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 57. (Non-WoS/Non-SCOPUS)
- Wah-Kheong Chan, Ida Normiha Hilmi, Phaik-Leng Cheah, Khean-Lee Goh. Progression of non-alcoholic fatty liver disease (NAFLD) a prospective clinicopathological follow-up study. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, page 42. (Non-WoS/Non-SCOPUS)
- Ahmad Najib Azmi, Wah-Kheong Chan, Sanjiv Mahadeva, Khean-Lee Goh. Split versus whole-dose PEG-ELS for bowel preparation in outpatient colonoscopy. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 29. (WoS)
- Wah-Kheong Chan, Norhaniza Bahar, Hamizah Razlan, Anushya Vijayananthan, Pavai Sthaneshwar, Khean-Lee Goh. Prevalence of NAFLD and associated factors among multi- racial Malaysian population. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 407. (WoS)
- Wah-Kheong Chan, Alexander Tong-Boon Tan, Shireene Ratna Vethakkan, Pei Chien Tah, Anushya Vijayananthan, Khean-Lee Goh. Ultrasonography-diagnosed NAFLD is not associated with IHD among long-standing poorly- controlled diabetics. J Gastroenterol Hepatol 2013; 28 (Suppl. 3): 407. (WoS)
2012
- W K Chan, P L Cheah, I N Hilmi, K L Goh. Clinical and histological follow-up of a cohort of patients with NAFLD. J Gastroenterol Hepatol 2012; 27 (Suppl. 5): 242. (WoS)
- W K Chan, A T B Tan, S R Vethakkan, P C Tah, A Vijayananthan, K L Goh. The role of diet and physical activity in non-alcoholic fatty liver disease (NAFLD) in diabetic patients. Proceeding The 3rd Asian-Pacific Topic Conference, page 175. (Non-WoS/Non-SCOPUS)
- W K Chan, A T B Tan, S R Vethakkan, P C Tah, A Vijayananthan, K L Goh. Prevalence of NAFLD among diabetic patients in the outpatient clinic of a Malaysian hospital and associated factors. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2012, page 55. (Non-WoS/Non-SCOPUS)
- W K Chan, A C Roslani, C W Law, K L Goh, S Mahadeva. Endoluminal clipping versus surgery in the management of iatrogenic colonic perforation: a direct cost analysis. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2012, page 117. (Non-WoS/Non-SCOPUS)
2011
- A N Azmi, W K Chan, S H Ho, K L Goh. Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre endoscopy unit. J Gastroenterol Hepatol 2011; 26 (Suppl. 5): 58. (WoS)
- W K Chan, A C Roslani, K L Goh, S Mahadeva. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital. J Gastroenterol Hepatol 2011; 26 (Suppl. 5): 117. (WoS)
- W K Chan, A C Roslani, K L Goh, S Mahadeva. Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, page 68. (Non-WoS/Non-SCOPUS)
- N A Azmi, W K Chan, S H Ho, K L Goh. Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit. Proceeding Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2011, page 46. (Non-WoS/Non-SCOPUS)
2010
- W K Chan, A Saravanan, J Manikam, K L Goh, S Mahadeva. Risk factors for poor bowel preparation and its impact on technical performance and patient comfort in an Asian population. J Gastroenterol Hepatol 2010; 25(Suppl. 2): A61. (WoS)
- W K Chan, K L Goh. Patient satisfaction with various aspects of an outpatient colonoscopy service. J Gastroenterol Hepatol 2010; 25 (Suppl. 2): A60. (WoS)
Editorial Material
2022
- Chan, W. K., & Wong, V. W. S. (2022). Meaning of non overlapping patients between the MAFLD and NAFLD definitions. [Editorial]. Liver International, 42(2), 271-273.
2021
- Pan, Z., Chan, W. K., & Eslam, M. (2021). The role of B cells in metabolic (dysfunction)-associated fatty liver disease. [Editorial]. Hepatobiliary Surgery and Nutrition, 10(6), 875.
- Chan, W.K. and Wong, V.W.-S. (2021). Editorial: metagenome-assembled genomes in non-alcoholic fatty liver disease. [Editorial]. Aliment Pharmacol Ther, 53: 755-756. https://doi.org/10.1111/apt.16280.
- Tan, S. S., Lee, Y. Y., Ali, R. A. R., Mustapha, F., & Chan, W. K. (2021). Endorsing the redefinition of fatty liver disease. [Editorial]. The Lancet Gastroenterology & Hepatology, 6(3), 163. https://doi.org/10.1016/S2468-1253(21)00002-9.
- Goh, G.B.-B., Chan, W.K. and Wong, V.W.-S. (2021), Breastfeeding to Prevent NAFLD. [Editorial]. Hepatology. https://doi.org/10.1002/hep.32095.
Meeting Abstract
2021
- Yu, M. L., El Kassas, M., Yilmaz, Y., Fernandez, M. C., Buti, M., Papatheodoridis, G., ... & Younossi, Z. M. (2021). Sa313 Clinical presentation and patient-reported outcomes in patients with chronic viral hepatitis: data from the Global Liver Registry . Gastroenterology, 160(6), S-821.
- Younossi, Z. M., Ong, J. P., Takahashi, H., Yilmaz, Y., Eguchi, Y., El Kassas, M., ... & Council, G. N. S. (2021). A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology.
- Younossi, Z. M., Yilmaz, Y., Yu, M. L., Wong, V., Fernandez, M. C., Isakov, V., ... & Stepanova, M. (2021). 342 Clinical presentation of lean non-alcoholic fatty liver disease (NAFLD) across the world: data from the Global NASH Registry. Gastroenterology, 160(6), S-771.
RESEARCH PROJECT
(Project title),(Role),(Duration),(Level)
(Project title),(Role),(Duration),(Level)
Private Funding
NONE
Pharmaceutical
The Swami Institute for International Medical Education Grant
Geran Penyelidikan Universiti Malaya (UMRG)
Madaus GmbH
Celsion
MSGH Research Grant
SUPERVISION
Postgraduate Student
(Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
(Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
Completed
- A study of non-alcoholic fatty liver disease using transient elastography and carotid intima media thickness using ultrasonography, Eugene Tan Choon Li, University of Malaya (UM) (Post Graduate Student)
- Clinical Fellows in Gastroenterology, Dr. Suresh Sithambaram, University of Malaya (UM) (Post Graduate Student)
- Masters Degree in Internal Medicine, Nor Suraya Samsudin, University of Malaya (UM) (Post Graduate Student)
- Patient Satisfaction of Outpatient Gastroscopy in University Malaya Medical Centre Endoscopy Unit, Ahmad Najib bin Azmi, University of Malaya (UM) (Post Graduate Student)
Ongoing
- Fibroscan as a non-invasive approach to predict the presence and size of varices in the Malaysian cirrhotic population, Lee Chong Chearn, University of Malaya (UM) (Post Graduate Student)
- MRI-based classification of liver fibrosis, Syaman a/l Harry, University of Malaya (UM) (Post Graduate Student)
- Shear wave elastography imaging for assessment of liver fibrosis in non-alcoholic fattyliver disease: correlation with transient elatography and histopathologic evaluation, Leong Wai Ling, University of Malaya (UM) (Post Graduate Student)
- Prevalence of advanced fibrosis due to non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus, Lai Lee Lee, University of Malaya (UM) (Post Graduate Student)
- Fibroscan as a non-invasive approach to predict the presence and size of varices in the Malaysian cirrhotic population, Kavitha A/P Sahadivanaidu, University of Malaya (UM) (Post Graduate Student)
- SARJANA PERUBATAN DALAMAN, Leong Lai Kuan, University of Malaya (UM) (Post Graduate Student)
- Sarjana Perubatan Dalaman, Ang Chui Mun, University of Malaya (UM) (Post Graduate Student)
UG Student/Clinical Fellowship
(Title of Thesis),(Academic Session)
(Title of Thesis),(Academic Session)
Completed
- MBBS, Yeoh Whei Chuern, Prevalence of fatty liver among outpatient diabetic patients in an Asian tertiary care hospital, 2011/2012
- MBBS, Ooi Chung Ping, Risk factors for fatty liver among outpatient diabetic patients in an Asian tertiary care hospital, 2011/2012
- MBBS, Choo Pee Terh, Randomized controlled trial: effect of split-dose versus whole-dose 2-liter polyethylene glycol electrolyte lavage solution (PEG-ELS) on patient tolerability of bowel preparation for colonoscopy, 2012/2013
- MBBS, Tan Wen Nian, Randomized controlled trial: effect of split-dose versus whole-dose 2-liter polyethylene glycol electrolyte lavage solution (PEG-ELS) on quality of bowel preparation for colonoscopy, 2012/2013
- MBBS, Ong Jes Mon, 2013/2014
- MBBS, Tan Zhun Foo, 2013/2014
- MBBS, Andrew Yeoh, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
- MBBS, Moh Jun Yuan, 2013/2014
- MBBS, Lai Su Meng, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
- MBBS, Stacey Lim, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
- MBBS, Jaclyn Lee, A study on the vertical transmission of hepatitis B virus infection in Malaysia, 2014/2015
Ongoing
- MBBS, Sumitra Ropini, A review of hepatocellular carcinoma from 2011 to 2014 in University Malaya Medical Centre, 2015/2016
- Mentor for MBBS Programme Kee Yan Shen, 2017/2018
SOCIAL RESPONSIBILITY ACTIVITIES
(Contribution to Society),(Duration),(Level)
(Contribution to Society),(Duration),(Level)
- Chairperson to VIRTUAL GUT 2020-Annual Scientific Meeting of MSGH, 27/11/2020 to 29/11/2020
- Moderator for Bariatric Endoscopy Live Global , 02/10/2020 to 02/10/2020
- Organizing committee for Asia Pacific Digestive Week 2020, 17/09/2020 to 20/09/2020
- Organising committee of Asian Pacific Digestive Week 2020 as the Scientific Co-Chair-Hepatology, 17/09/2020 to 20/09/2020
- Bid Committee for Asia Pacific Digestive Week 2020, 17/09/2020 to 20/09/2020
- Moderator for Web Symposium SEA NAFLD Summit 2020, 28/07/2020 to 28/07/2020
- Chairperson for Live Webinar: "Find the Missing Millions" (Advanced Treatments for Hepatitis), 26/07/2020 to 26/07/2020
- Chairperson for Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019 , 16/08/2019 to 18/08/2019
- Chairperson for Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, 16/08/2019 to 18/08/2019
- Organizing Committe for Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology GUT2019, 16/08/2019 to 18/08/2019
- Organizing Committee for Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology (GUT 2018), 13/07/2018 to 15/07/2018
- Organizing committee for Annual Scientific Meeting MSGH (GUT 2018), 13/07/2018 to 15/07/2018
- Chairperson for Hepatitis B Tea Satellite Symposium (GUT 2018), 13/07/2018 to 15/07/2018
- Chairperson for Hepatitis B Symposium (GUT 2018), 13/07/2018 to 15/07/2018
- Co-Course Director for Basic EUS Course 2018, 06/04/2018 to 06/04/2018
- Co-Course Director for Endoscopy 2018, 06/04/2018 to 08/04/2018
- Organizing Committee for MSGH Update in Gastroenterology and Hepatology 2018, 03/03/2018 to 03/03/2018
- Organizing Committee for GUT 2017, 11/08/2017 to 13/08/2017
- Chairperson for GUT 2017, 11/08/2017 to 13/08/2017
- Chairperson of Annual Scientific Meeting of the Indian National Association for Study of the Liver (25th silver jubilee) 2017, 05/08/2017 to 05/08/2017
- Chairperson for Hot Topics in Hepatology Symposium , 02/06/2017 to 03/06/2017
- Coordinator for Endoscopy 2017, 07/04/2017 to 09/04/2017
- Course Co-Directors for Endoscopy 2017, 07/04/2017 to 09/04/2017
- Organizing Committee for Endoscopy 2017, 07/04/2017 to 09/04/2017
- Organizing Committee for MSGH Update in Gastroenterology and Hepatology, 04/03/2017 to 04/03/2017
- Chairperson in Asian Pacific Digestive Week APDW 2016, 02/11/2016 to 05/11/2016
- Organizing Committee GUT 2016, 22/07/2016 to 24/07/2016
- Chairperson for GUT 2016, 22/07/2016 to 24/07/2016
- Organizing Committee for Endoscopy 2016, 08/04/2016 to 10/04/2016
- Co-Course Director for EUS-Cytopathology Hands-On Workshop 2015, 21/12/2015 to 21/12/2015
- Organizing Committee for 2015 Advanced EUS Workshop, 21/12/2015 to 21/12/2015
- Organizing Committee for Endoscopy 2015: Maintaining Quality in Endoscopy, 17/04/2015 to 19/04/2015
- Assistant Course Director for the 2nd Advanced EUS Workshop 2014, 13/10/2014 to 13/10/2014
- Organizing Committee for Endoscopy 2014: The Best Tips in Therapeutic Endoscopy , 28/03/2014 to 30/03/2014
- Course Coordinator for Basic Endoscopy Course 2013, 2013
- Course Coordinator for Gastrointestinal Motility Workshop 2013, 2013
- Assistant Course Coordinator for Asian EUS Group Workshop 2013, 2013
- Course Coordinator for GIA Course 2013 , 2013
- Organizing Committee for Endoscopy 2013: Advancing the Practice of Endoscopy, 12/04/2013 to 14/04/2013
- Organizing Committee for Endoscopy 2012: Therapeutic Endoscopy in the Global World, 30/03/2012 to 01/04/2012
- Organizing Committee for 1st ERBE-UMMC Training Workshop in Therapeutic Endoscopy, 01/07/2011 to 01/07/2011
- Organizing Committee for Endoscopy 2011: What's New and What's Good for Our Patients, 14/04/2011 to 17/04/2011
ACADEMIC/PROFESSIONAL SERVICES
Academic/Professional Services
(Contribution),(Duration),(Level),(Role)
(Contribution),(Duration),(Level),(Role)
AWARD AND STEWARDSHIP
(Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
(Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
- Best Paper Award for Second place in the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2017, Malaysian Society of Gastroenterology and Hepatology, 2017 (RESEARCH)
- CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2017 (CERTIFICATE)
- Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2016, Malaysian Society of Gastroenterology and Hepatology, 2016 (RESEARCH)
- CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2015 (CERTIFICATE)
- Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, Malaysian Society of Gastroenterology and Hepatology, 2015 (RESEARCH)
- Asian Young Endoscopist Award 2015, Koran Society of Gastrointestinal Endoscopy, 2015 (OTHERS)
- APDWF Posters of Distinction Award, Asian Pacific Digestive Week Federation, 2015 (RESEARCH)
- Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2015, Malaysian Society of Gastroenterology and Hepatology, 2015 (RESEARCH)
- Poster of Distinction: Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease,at the 23rd Conference of the Asian Pacific Association in the Study of the Liver 2014, Asian Pacific Association in the Study of the Liver 2014, 2014 (RESEARCH)
- EXCELLENCE SERVICE AWARD, University of Malaya, 2013 (CERTIFICATE)
- Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2013, Malaysian Society of Gastroenterology and Hepatology, 2013 (RESEARCH)
- Best Paper Award 1st Prize at the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology GUT 2012, Malaysian Society of Gastroenterology and Hepatology, 2012 (RESEARCH)
- Scholarship as Visiting Scholar to Kyushu University Hospital, Kyushu University Hospital, 2011 (SPECIAL)
CONSULTANCY PROJECT
(Project title),(Organisation),(Duration),(Role),(Level)
(Project title),(Organisation),(Duration),(Role),(Level)
- Consultant Gastroenterologist, University of Malaya Specialist Centre, 01/12/2014 to 01/12/2020 (National)
- Reaching a Consensus on Optimising the Use of Nexavar in HCC., Bayer HealthCare Pharmaceuticals, 01/10/2014 to 01/10/2014 (National)
- Consultant Gastroenterologist, University of Malaya Medical Centre, 01/12/2013 to 01/12/2020 (National)
PAPER PRESENTED
(Title),(Event),(Date Presented),(Organiser),(Level)
(Title),(Event),(Date Presented),(Organiser),(Level)
PLENARY SPEAKER
INVITED SPEAKER
ORAL PRESENTER
POSTER PRESENTER
PRESENTER
OTHERS